Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Q32 Bio (QTTB) Total Liabilities (2017 - 2025)

Q32 Bio (QTTB) has 9 years of Total Liabilities data on record, last reported at $19.8 million in Q4 2025.

  • For Q4 2025, Total Liabilities fell 77.2% year-over-year to $19.8 million; the TTM value through Dec 2025 reached $19.8 million, down 77.2%, while the annual FY2025 figure was $19.8 million, 77.2% down from the prior year.
  • Total Liabilities reached $19.8 million in Q4 2025 per QTTB's latest filing, down from $76.2 million in the prior quarter.
  • Across five years, Total Liabilities topped out at $118.5 million in Q4 2023 and bottomed at $19.8 million in Q4 2025.
  • Average Total Liabilities over 5 years is $61.3 million, with a median of $51.2 million recorded in 2022.
  • Peak YoY movement for Total Liabilities: soared 134.76% in 2023, then tumbled 77.2% in 2025.
  • A 5-year view of Total Liabilities shows it stood at $42.1 million in 2021, then grew by 20.02% to $50.5 million in 2022, then skyrocketed by 134.76% to $118.5 million in 2023, then fell by 26.89% to $86.7 million in 2024, then crashed by 77.2% to $19.8 million in 2025.
  • Per Business Quant database, its latest 3 readings for Total Liabilities were $19.8 million in Q4 2025, $76.2 million in Q3 2025, and $78.4 million in Q2 2025.